Tyche Industries Quarterly Results for Trading Insights

TYCHE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹12 Cr
QMarch 2025
Quarterly Results

Tyche Industries Quarterly Results Key Highlights

  • Revenue of ₹73 Cr in March 2025 (+0.0% vs March 2025, -2.7% vs March 2024)
  • Net Profit of ₹12 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹19 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 17.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹12.20 in March 2025 (+0.0% vs March 2025)

Tyche Industries Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 66 73 75 80 66 -9.6% -
Net Profit (₹ Cr) 10 12 12 14 9 - -
EBITDA (₹ Cr) 15 19 19 21 15 - -
EPS (₹) 9.50 12.20 11.78 13.74 9.18 - -
Operating Margin (%) 10.0% 17.0% 18.0% 21.0% 18.0% - -

Tyche Industries Share Price Trend Around Quarterly Results

Visualize Tyche Industries's 1-year price movement across quarterly results — ideal for logging trades in Tyche Industries share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 16.4%
EBITDA Margin 26.0%
Operating Margin 17.0%
ROE (Annual) 8.8%

Balance Sheet Highlights

Total Assets ₹147 Cr
Total Equity ₹137 Cr
Current Assets ₹121 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹9 Cr
Investing Cash Flow ₹-1 Cr
Financing Cash Flow ₹-3 Cr
Net Cash Flow ₹5 Cr

Current Market Data

Current Price ₹117.95
Exchange BSE
Last Updated Jan 09, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Tyche Industries quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹417,052.40 Cr 1729.9 14,875 3,125 +10.8% - 21.0% 133.1
Divis Laboratories
Sept 2025
₹176,337.50 Cr 6616.5 2,860 689 +7.1% - 24.1% 254.8
Torrent Pharmaceuti…
Sept 2025
₹136,522.12 Cr 3963.4 3,219 591 +11.3% - 18.4% 226.0
Cipla
Sept 2025
₹118,572.82 Cr 1465.7 7,716 1,353 +12.0% - 17.5% 87.6
Dr Reddys Laborator…
Sept 2025
₹100,998.62 Cr 1210.1 9,135 1,337 +1.1% - 14.6% 74.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores